Simon Nayyar

Sep 25, 2023 | investing.thisismoney.co.uk | Clarissa Sowemimo-Coker |Emily Staples |Jo Turner |Simon Nayyar

RNS Number : 4227N Oxford Cannabinoid Tech.Holdings 25 September 2023 Oxford Cannabinoid Technologies Holdings plc ("OCTP" or the "Company") Final Dose Administered in Phase I Clinical Trial for Lead Drug Candidate OCT461201 Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), the pharmaceutical company developing prescription cannabinoid medicines, is pleased to announce that the final dose of its lead pharmaceutical drug compound, OCT461201, has been successfully administered, as part...